TAVR patients with moderate or greater TR may face increased risks
When TAVR patients present with moderate or greater tricuspid regurgitation, it could impact the care team’s treatment strategy of choice.
When TAVR patients present with moderate or greater tricuspid regurgitation, it could impact the care team’s treatment strategy of choice.
The Hani Najm Global Scholar Award was established to encourage the sharing of knowledge between international cardiology professionals to better combat the devastating effects of…
Speaker(s): Ansell , Jack Bakhru , Sasha H Balaj , Anita Chen , Lirong Jiang , Xuan Kronen , Kelly Rose LaDuca , Frank Mootoo…
The group highlighted the proven effectiveness of these drugs, especially semaglutide and tirzepatide, while noting that eligibility, affordability and availability will still play key roles…
At the Forefront of Cardiothoracic Surgery, AATS members have a proven record of distinction within the specialty and have made significant contributions to the care…
The group highlighted the proven effectiveness of these drugs, especially semaglutide and tirzepatide, while noting that eligibility, affordability and availability will still play key roles…
Your access to the latest cardiovascular news, science, tools and resources.
The new Class I recall includes nearly 27,000 devices that could potentially experience a harmful defect during use.
BackgroundPhysical activity (PA) is known to protect against incident hypertension, but the preferred intensity of PA to prevent hypertension remains unknown. Energy expenditure (EE) in…
Nominations are due by June 23, 2023. Submit your nominations today!
After their proposal for a new American Board of Cardiovascular Medicine was shot down earlier this year, cardiology groups have asked the AMA for some…